These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 36987861)

  • 1. Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing.
    Tong R; Luo L; Zhao Y; Sun M; Li R; Zhong J; Chen Y; Hu L; Li Z; Shi J; Lyu Y; Hu L; Guo X; Liu Q; Shuang T; Zhang C; Yuan A; Sun L; Zhang Z; Qian K; Chen L; Lin W; Chen AF; Wang F; Pu J
    Emerg Microbes Infect; 2023 Dec; 12(1):e2187245. PubMed ID: 36987861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing.
    He B; Liu S; Xu M; Hu Y; Lv K; Wang Y; Ma Y; Zhai Y; Yue X; Liu L; Lu H; Zhou S; Li P; Mai G; Huang X; Li C; Chen S; Ye S; Zhao P; Yang Y; Li X; Jie Y; Shi M; Yang J; Shu Y; Chen YQ
    Emerg Microbes Infect; 2022 Dec; 11(1):2007-2020. PubMed ID: 35899581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2.
    Badano MN; Sabbione F; Keitelman I; Pereson M; Aloisi N; Colado A; Ramos MV; Ortiz Wilczyñski JM; Pozner RG; Castillo L; Wigdorovitz G; E de Bracco MM; Fink S; Chuit R; Baré P
    Mol Immunol; 2022 Mar; 143():94-99. PubMed ID: 35091231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune features revealed by single-cell RNA and single-cell TCR/BCR sequencing in patients with rheumatoid arthritis receiving COVID-19 booster vaccination.
    Fan Y; Huang S; Wu D; Chu M; Zhao J; Zhang J; Wang Y; Gui Y; Ye X; Wang G; Geng Y; Wang Y; Zhang Z
    J Med Virol; 2024 Apr; 96(4):e29573. PubMed ID: 38566569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered T-cell receptor β repertoire in adults with SARS CoV-2 inactivated vaccine of BBIBP-CorV.
    Quan Z; Qi A; Ma S; Li Y; Chen H; Yu X; Dong T; Li K; Qiu Y
    Mol Immunol; 2023 Oct; 162():54-63. PubMed ID: 37647774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodominant SARS-CoV-2-specific CD4
    Ning J; Wang Q; Chen Y; He T; Zhang F; Chen X; Shi L; Zhai A; Li B; Wu C
    J Med Virol; 2023 Apr; 95(4):e28743. PubMed ID: 37185843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine.
    Yin J; Zhao Y; Huang F; Yang Y; Huang Y; Zhuang Z; Wang Y; Wang Z; Lin X; Zheng Y; Zhou W; Wang S; Xu Z; Ye B; Guo Y; Lei W; Li L; Tian J; Gan J; Wang H; Wang W; Ma P; Liu C; Wei X; Shi X; Wang Z; Wang Y; Liu Y; Yang M; Yuan Y; Song Y; Ma W; Huang Z; Liu Y; Huang Y; Lu H; Liu P; Liang H; Hou Y; Xu X; Liu L; Zhang Y; Wu G; Gao GF; Jin X; Liu C; Yang X; Liu WJ
    Innovation (Camb); 2023 Jan; 4(1):100359. PubMed ID: 36506806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans.
    Vályi-Nagy I; Matula Z; Gönczi M; Tasnády S; Bekő G; Réti M; Ajzner É; Uher F
    Geroscience; 2021 Oct; 43(5):2321-2331. PubMed ID: 34633612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2.
    Szabó E; Modok S; Rónaszéki B; Faragó A; Gémes N; Nagy LI; Hackler L; Farkas K; Neuperger P; Balog JÁ; Balog A; Puskás LG; Szebeni GJ
    Front Med (Lausanne); 2023; 10():1176168. PubMed ID: 37529238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2.
    Mahmoud S; Ganesan S; Al Kaabi N; Naik S; Elavalli S; Gopinath P; Ali AM; Bazzi L; Warren K; Zaher WA; Hosani FA
    J Clin Virol; 2022 Jun; 150-151():105161. PubMed ID: 35439702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study.
    Wen GP; Zhu M; Li LR; Li XJ; Ye HM; Zhou YL
    Front Immunol; 2023; 14():1099629. PubMed ID: 36817474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination.
    Wang F; Huang B; Lv H; Feng L; Ren W; Wang X; Tang L; Liu Q; Wu D; Zheng H; An Z; Deng Y; Zhao L; Ye F; Wang W; Zhang H; Chang S; Liao Y; Chen F; Rodewald LE; Gao GF; Yin Z; Tan W
    Front Immunol; 2022; 13():967051. PubMed ID: 36159863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals.
    Mallah SI; Alawadhi A; Jawad J; Wasif P; Alsaffar B; Alalawi E; Mohamed AM; Butler AE; Alalawi B; Qayed D; Almahari SA; Mubarak A; Mubarak A; Saeed S; Humaidan A; Kumar N; Atkin S; Alqahtani M
    Vaccine; 2023 Mar; 41(12):1925-1933. PubMed ID: 36725431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV.
    Lv Z; Lv S; Li Q; Xia Y; Feng Z; Zhang H; Yang H; Wu Z; Zou N; Mo Q; Gu Q; Ying S; Wang X; Qin D; Wan C
    Front Immunol; 2023; 14():1264160. PubMed ID: 38045691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated CD8
    Dou X; Peng M; Jiang R; Li W; Zhang X
    Front Immunol; 2023; 14():1174406. PubMed ID: 37654490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine.
    Chen Y; Yin S; Tong X; Tao Y; Ni J; Pan J; Li M; Wan Y; Mao M; Xiong Y; Yan X; Yang Y; Huang R; Wu C; Shen H
    Clin Microbiol Infect; 2022 Mar; 28(3):410-418. PubMed ID: 34715346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients.
    Souan L; Abdel-Razeq H; Al Zughbieh M; Al Badr S; Sughayer MA
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different T-cell and B-cell repertoire elicited by the SARS-CoV-2 inactivated vaccine and S1 subunit vaccine in rhesus macaques.
    Qin L; Zuo Y; Liu S; Li B; Wang H; Li H; Li J; Chen Y; Sun M; Zheng H
    Hum Vaccin Immunother; 2022 Nov; 18(6):2118477. PubMed ID: 36070519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.
    Kaabi NA; Yang YK; Du LF; Xu K; Shao S; Liang Y; Kang Y; Su JG; Zhang J; Yang T; Hussein S; ElDein MS; Yang SS; Lei W; Gao XJ; Jiang Z; Cong X; Tan Y; Wang H; Li M; Mekki HM; Zaher W; Mahmoud S; Zhang X; Qu C; Liu DY; Zhang J; Yang M; Eltantawy I; Hou JW; Lei ZH; Xiao P; Wang ZN; Yin JL; Mao XY; Zhang J; Qu L; Zhang YT; Yang XM; Wu G; Li QM
    Nat Commun; 2022 Jun; 13(1):3654. PubMed ID: 35760812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.